Reducing dementia in rheumatoid arthritis patients – AlKhaleej Today

The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biological or targeted synthetic disease-modifying anti-inflammatory drugs (DMARDs) than in patients receiving conventional synthetic DMARDs, according to a new study. The study was presented at the American College of Rheumatologys annual virtual meeting. Taking a biological or targeted synthetic DMARD reduced the risk of dementia by 17% compared to patients who received only a conventional synthetic…

Click here to view the original article.